A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Mishra, Rasmi Rekha ^a   Chaudhary, Jitendra Kumar ^a   Bajaj, Gagan Deep ^a   Rath, Pramod C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY AND PHOSPHATASE AND TENSIN HOMOLOGUE DELETED FROM HUMAN CHROMOSOME 10 HOMOLOGOUS INOSITOL LIPID PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; TPIP (PROTEIN);

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ALU SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL ADHESION; CELL CYCLE REGULATION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 13; COMPUTER MODEL; CONTROLLED STUDY; DNA LIBRARY; GENE LOCUS; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HEART; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LONG INTERSPERSED REPEAT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; TESTIS; ANIMAL; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; KIDNEY; METABOLISM; RAT; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; ANIMALS; CARRIER PROTEINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HELA CELLS; HUMANS; KIDNEY; MALE; MICE; OPEN READING FRAMES; RATS; RNA, MESSENGER; TESTIS; TISSUE DISTRIBUTION;

EID: 82555202982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028433     Document Type: Article

References (44)

1. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, et al. (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 352-362.
2. Li DM, Sun H, (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor 1. Cancer Res 57: 2124-2129.
3. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
4. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67.
5. Gustafson S, Zbuk KM, Scacheri C, Eng C, (2007) Cowden syndrome. Semin Oncol 34: 428-434.
6. Sansal I, Sellers WR, (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22: 2954-2963.
7. Wang X, Jiang X, (2008) PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res 18: 807-816.
8. Carnero A, (2010) The PKB/AKT pathway in cancer. Curr Pharm Des 16: 34-44.
9. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, et al. (1997) PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A 94: 9052-9057.
10. Maehama T, Dixon JE, (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 273: 13375-13378.
11. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334.
12. Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, et al. (2000) Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60: 7033-7038.
13. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR, (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: 5010-8.
14. Eng C, (2003) PTEN: One gene, many syndromes. Hum Mutat 22: 183-198.
15. Das S, Dixon JE, Cho W, (2003) Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci U S A 100: 7491-7496.
16. Leslie NR, Yang X, Downes CP, Weijer CJ, (2005) The regulation of cell migration by PTEN. Biochem Soc Trans 33: 1507-1508.
17. Odriozola L, Singh G, Hoang T, Chan AM, (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem 282: 23306-23315.
18. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A, (2004) Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303: 1179-1181.
19. Meuillet EJ, Mahadevan D, Berggren M, Coon A, Garth P, (2004) Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429: 123-133.
20. Mehenni H, Lin-Marq N, Buchet-Poyau K, Reymond A, Collart MA, et al. (2005) LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet 14: 2209-2219.
21. Zhou M, Gu L, Findley HW, Jiang R, Woods WG, (2003) PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Res 63: 6357-6362.
22. Tang Y, Eng C, (2006) PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res 66: 736-742.
23. Chen H, Rossier C, Morris MA, Scott HS, Gos A, et al. (1999) A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y. Hum Genet 105: 399-409.
24. Guipponi M, Yaspo ML, Riesselman L, Chen H, Sario ADe, et al. (2000) Genomic structure of a copy of the human TPTE gene which encompasses 87 kb on the short arm of chromosome 21. Human Genet 107: 127-131.
25. Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, et al. (2003) The TPTE gene family: cellular expression, subcellular localization and alternative splicing. Gene 323: 189-199.
26. Walker SM, Downes CP, Leslie NR, (2001) TPIP: a novel phosphoinositide 3-phosphatase. Biochem J 360: 277-283.
27. Bajaj GD, (2002) Molecular cloning and characterization of human cDNAs by a simple repeat DNA probe: Identification of novel candidate genes. Ph.D. Thesis, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
28. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
29. Agrawal S, Eng C, (2006) Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum Mol Genet 15: 777-787.
30. Babich V, Aksenov N, Alexeenko V, Oei SL, Buchlow G, et al. (1999) Association of some potential hormone response elements in human genes with Alu family repeats. Gene 239: 341-349.
31. Yang Z, Boffelli D, Boonmark N, Schwartz K, Lawn R, (1998) Apolipoprotein(a) gene enhancer resides within a LINE element. J Biol Chem 273: 891-897.
32. Wu Y, Dowbenko D, Pisabarro M, Dillard-Telm L, Koeppen H, et al. (2001) PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase. J Biol Chem 276: 21745-21753.
33. Rizo J, Südhof TC, (1998) C2 domain, structure and function of a universal Ca2+-binding domain. J Biol Chem 273: 15879-15882.
34. Rahdar M, Inoue T, Meyer T, Zhang J, Vazquez F, et al. (2009) A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A 106: 480-485.
35. Lee JJ, Kim BC, Park MJ, Lee YS, Kim YN, et al. (2011) PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ 18: 666-677.
36. Lehman JA, Waning DL, Batuello CN, Cipriano R, Kadakia MP, et al. (2011) Induction of apoptotic genes by a p73-PTEN complex in response to genotoxic stress. J Biol Chem 286: 36631-36640.
37. Maier D, Jones G, Li X, Schonthal AH, Gratzl O, et al. (1999) The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 59: 5479-5482.
38. Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, et al. (2004) PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23: 6788-6797.
39. Li AG, Piluso LG, Cai X, Wei G, Sellers WR, et al. (2006) Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23: 575-587.
40. Tian T, Nan KJ, Wang SH, Liang X, Lu CX, et al. (2010) PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and-independent mechanisms in HepG2 cells. Carcinogenesis 31: 1211-1219.
41. Cabarcas S, Watabe K, Schramm L, (2010) Inhibition of U6 snRNA transcription by PTEN. Online J Biol Sci 10: 114-125.
42. Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, et al. (2010) the structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468: 447-451.
43. Dey I, Rath PC, (2005) A novel rat genomic simple repeat DNA with RNA-homology shows triplex (H-DNA)-like structure and tissue-specific RNA expression. Biochem Biophys Res Commun 327: 276-286.
44. Sambrook J, Russell DW, (2001) Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor Laboratory Press, New York.